Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus

MILWAUKEE, May 3, 2023 /PRNewswire/ — Ademi LLP is investigating Magenta (Nasdaq: MGTA) for possible breaches of fiduciary duty and other violations of law in its transaction with Dianthus. Click here to learn how to join the action https://www.ademilaw.com/case/magenta-therapeutics-inc…